Peptide Initiative

Peptide history · 1965

Enalapril Maleate (Vasotec)

Snake venom becomes life-saving medicine

FDA approved, widely prescribed1965 – 2026

In 1965, a Brazilian scientist made an amazing discovery. A venomous snake's venom had the power to lower blood pressure. Within 20 years, scientists turned this poison into one of the most important drugs ever made. Enalapril has saved millions of lives. This is the incredible story of how nature's deadliest weapon became medicine.

1965Discovery Year

When this peptide was first identified

PeptideType

Compound classification

FDA approved, widely prescribedStatus

Current regulatory status

Research compoundPrimary Use

Main area of investigation

InjectionAdministration

How this peptide is typically given

Peptide chainSize

Molecular structure type

  • Sergio Henrique Ferreira

    University of São Paulo, Brazil

    Brazilian pharmacologist who discovered that Brazilian pit viper venom contained a peptide that lowers blood pressure. He called it bradykinin-potentiating factor (BPF). This changed everything.

  • David Cushman & Miguel Ondetti

    Squibb Institute for Medical Research, Princeton, NJ

    Scientists at Squibb Institute designed captopril and enalapril based on Ferreira's discovery. They figured out how to create synthetic versions of the snake venom peptides. These became the first ACE inhibitors.

  • John Vane

    Royal College of Surgeons of England, London

    Pharmacologist who helped connect snake venom research to ACE inhibitor design. Won a Nobel Prize for his work on aspirin and prostaglandins.

  1. The Discovery

    The Mysterious Viper

    In the jungles of Brazil, a deadly pit viper called Bothrops jararaca kills its prey in an unusua...

    Key moment

    He discovered that the venom contained small peptides that blocked an enzyme in the blood.

    In the jungles of Brazil, a deadly pit viper called Bothrops jararaca kills its prey in an unusual way. When it bites, its venom doesn't just cause pain — it makes the victim's blood pressure drop so fast they pass out. In the 1960s, a young Brazilian pharmacologist named Sergio Ferreira became fascinated by this effect. He traveled to London to study the venom at the Royal College of Surgeons. He discovered that the venom contained small peptides that blocked an enzyme in the blood. This enzyme, called ACE, normally helps keep blood pressure stable. The snake's venom shut it down completely. Ferreira realized that if you could control this effect, you might cure high blood pressure.

  2. The Breakthrough

    The Deadly Discovery

    Ferreira published his findings, and they caught the attention of scientists at the Squibb Instit...

    Key moment

    It was the first ACE inhibitor ever made.

    Ferreira published his findings, and they caught the attention of scientists at the Squibb Institute in New Jersey. A biochemist named David Cushman and a chemist named Miguel Ondetti began working together to understand exactly how the snake venom peptides worked. They studied the three-dimensional shape of the ACE enzyme. They tested hundreds of snake venom fragments. By 1977, they had designed a completely new molecule that could block ACE — but unlike snake venom, it was safe for humans. They called it captopril. It was the first ACE inhibitor ever made. But captopril had problems: it tasted bad, caused rashes, and patients had to take it three times a day.

  3. The Trials

    The Connection

    The Merck pharmaceutical company saw the potential and wanted to make something better.

    Key moment

    The Merck pharmaceutical company saw the potential and wanted to make something better.

    The Merck pharmaceutical company saw the potential and wanted to make something better. Their scientists studied captopril's structure and realized they could redesign it. They needed a molecule that blocked ACE just as well but caused fewer side effects and lasted longer in the body. The team, led by chemist Arthur Patchett, spent years testing variations. They discovered that by adding a specific chemical group called an ethyl ester, they could create a prodrug — a molecule that was inactive when swallowed but became active once the liver processed it. This was the key insight that separated enalapril from captopril.

  4. The Crisis

    The Design

    Enalapril was designed to be swallowed as a pill.

    Key moment

    Enalapril was designed to be swallowed as a pill.

    Enalapril was designed to be swallowed as a pill. Once it reached the liver, enzymes would strip off the ethyl ester group, converting it into its active form called enalaprilat. This was elegant chemistry. The prodrug approach meant the medicine entered the bloodstream slowly and steadily, so patients only needed to take it once or twice a day instead of three times. Clinical trials showed it worked just as well as captopril at lowering blood pressure but caused far fewer side effects. The rashes and taste problems were gone. Merck filed for FDA approval in 1985.

  5. The Legacy

    The Miracle Drug

    The FDA approved enalapril under the brand name Vasotec in 1985.

    Key moment

    The FDA approved enalapril under the brand name Vasotec in 1985.

    The FDA approved enalapril under the brand name Vasotec in 1985. It became one of the best-selling drugs in history. Doctors prescribed it to millions of patients with high blood pressure and heart failure. Later studies showed that ACE inhibitors didn't just lower blood pressure — they actually protected the kidneys in diabetic patients and helped the heart heal after heart attacks. Today, enalapril is on the World Health Organization's List of Essential Medicines. It costs pennies per pill in generic form. The story that began with a deadly snake in Brazil ended with one of the safest, cheapest, and most widely used heart medicines on Earth. Over a billion people have taken ACE inhibitors since enalapril's approval.

15 milestones, 1965 – 2026.

  1. 1965Sergio Ferreira discovers bradykinin-potentiating factor in Brazilian pit viper venom
  2. 1967Ferreira publishes research showing venom peptides lower blood pressure in animals
  3. 1970Scientists at NIH confirm ACE enzyme is the key blood pressure control switch
  4. 1973John Vane learns about Ferreira's snake venom work and tells Squibb colleagues
  5. 1975Cushman and Ondetti begin designing synthetic ACE inhibitors at Squibb
  6. 1977Captopril created and tested, showing excellent blood pressure control
  7. 1978Enalapril designed as an improvement to captopril
  8. 1981Large clinical trials show enalapril is safe and effective in thousands of patients
  9. 1983Enalapril submitted to FDA for approval
  10. 1985FDA approves enalapril (Vasotec) for high blood pressure treatment
  11. 1987Studies show enalapril protects hearts in heart failure patients
  12. 1990Enalapril becomes one of the top 10 prescribed drugs worldwide
  13. 2000Over 100 million people worldwide have taken enalapril
  14. 2010Research shows enalapril protects diabetic kidneys from damage
  15. 2026Enalapril continues as a standard first-line hypertension treatment globally

Enalapril is a small chemical made of 20 carbon atoms and other elements. Its full name is complicated: (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid. But what it does is simple: it blocks ACE. ACE stands for angiotensin-converting enzyme. This enzyme tightens blood vessels. When enalapril blocks ACE, blood vessels relax. Blood pressure drops. The heart pumps easier. The kidneys work better. Enalapril is based on a peptide structure found in snake venom, which shows how nature invented a solution to blood pressure long before humans.

Real stories, real lives

  • James's Turnaround

    James had high blood pressure for ten years. Nothing seemed to work well. His first doctor tried three different medicines, but they caused bad side effects. James felt tired and depressed. Then a new doctor prescribed enalapril. Within two weeks, his blood pressure dropped to normal levels. He had no side effects. He felt energetic again. Twenty years later, James is still taking enalapril. He says the medicine saved his life and his marriage. He never knew that a deadly snake in Brazil made the solution.
  • Rosa's Second Chance

    Rosa had a heart attack at age 55. Her heart was badly damaged and weak. Doctors said she had heart failure and would likely need a transplant. They started her on enalapril along with other heart medicines. After three months, her heart began to strengthen. Her symptoms improved dramatically. Five years later, Rosa's heart function returned to nearly normal. Doctors were amazed. Enalapril had given her a second chance at life. Today she runs a support group for heart patients and tells everyone about the snake venom medicine that saved her.

The future of Enalapril

  • Heart Failure Prevention

    Clinical trials are exploring whether early Enalapril therapy can prevent heart failure progression.

  • Long-Acting Formulations

    Pharmaceutical companies are developing sustained-release versions of Enalapril that last longer in the body.

  • Combination Cardiovascular Therapy

    Researchers are testing Enalapril alongside existing heart medications for improved patient outcomes.

Be inspired

The story of Enalapril is ultimately about the relentless pursuit of better medicine for humanity.

Continue the legacy. The next breakthrough could be yours.

Enalapril Chronicles. Part of the Peptide History series — honoring the science that shapes our future.

This content is for educational purposes only and should not be considered medical advice.